GLAXOSMITHKLINE PHARMA LT Peer Comparison
GLAXO · Healthcare · Current price ₹2,932.1
Peers tracked
11
GLAXOSMITHKLINE PHARMA LT P/E
48.0x
Sector
Healthcare
GLAXOSMITHKLINE PHARMA LT vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,929 | 39.1x | 4,62,808 |
| DIVI S LABORATORIES LTD | ₹9,165 | 69.1x | 2,43,116 |
| TORRENT PHARMACEUTICALS L | ₹4,965.5 | 72.9x | 1,68,098 |
| ZYDUS LIFESCIENCES LTD | ₹1,167.8 | 22.0x | 1,17,513 |
| CIPLA LTD | ₹1,423 | 30.3x | 1,14,239 |
| LAURUS LABS LIMITED | ₹1,861.6 | 92.8x | 98,277 |
| LUPIN LIMITED | ₹2,153 | 20.6x | 98,042 |
| MANKIND PHARMA LIMITED | ₹2,356.5 | 53.7x | 97,768 |
| AUROBINDO PHARMA LTD | ₹1,683.3 | 25.9x | 97,124 |
| DR. REDDY S LABORATORIES | ₹1,171 | 26.8x | 97,068 |
| GLAXOSMITHKLINE PHARMA LT | ₹2,996.1 | 39.5x | 50,309 |
GLAXOSMITHKLINE PHARMA LT versus its peers
GLAXOSMITHKLINE PHARMA LT operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 48.0x may be cheap in one industry and expensive in another.
More on GLAXOSMITHKLINE PHARMA LT
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.